Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy

Simple item page
dc.contributor.authorÖzbakkaloǧlu B.
dc.contributor.authorTünger Ö.
dc.contributor.authorSürücüoǧlu S.
dc.contributor.authorLekili M.
dc.contributor.authorKandiloglu A.R.
dc.date.accessioned2024-07-22T08:25:42Z
dc.date.available2024-07-22T08:25:42Z
dc.date.issued1999
dc.description.abstractAlthough intravesical bacillus Calmette-Guerin (BCG) administration is an effective method in the treatment of superficial urinary bladder carcinoma, some complications may arise such as a granulomatous reaction either in the urinary tract or, in rare cases, outside the urinary tract. We report in this paper a case of granulomatous hepatitis following intravesical BCG administration.
dc.identifier.DOI-ID10.1023/A:1007119706336
dc.identifier.issn03011623
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/20560
dc.language.isoEnglish
dc.subjectAdjuvants, Immunologic
dc.subjectAdministration, Intravesical
dc.subjectBCG Vaccine
dc.subjectCarcinoma, Transitional Cell
dc.subjectGranuloma
dc.subjectHepatitis
dc.subjectHumans
dc.subjectLiver
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectUrinary Bladder Neoplasms
dc.subjectBCG vaccine
dc.subjectadult
dc.subjectarticle
dc.subjectBCG vaccination
dc.subjectbladder carcinoma
dc.subjectcancer recurrence
dc.subjectcase report
dc.subjectcomputer assisted tomography
dc.subjectcystoscopy
dc.subjectechography
dc.subjectgranulomatous hepatitis
dc.subjecthematuria
dc.subjecthepatomegaly
dc.subjecthistopathology
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectintravesical drug administration
dc.subjectliver function test
dc.subjectmale
dc.subjecttransitional cell carcinoma
dc.subjecttransurethral resection
dc.titleGranulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy
dc.typeArticle

Files

Collections

Scopus Koleksiyonu